cjc1295 no dac 5mg & ipamorelin 5mg CJC-1295 (NO DAC) + 5mg+5mg CJC-1295 without DAC 5mg +
Description
Martinez, V
doi: 10.1016/j.phyplu.2023.100479
& Fenicheil, P
In a follow-up trial conducted by the JPLSG between 2011 and 2015, allocation to HSCT in first CR was restricted to the patients with KMT2A rearrangements and classified as high risk (age 300,000/L or a prednisolone poor responder), the 5-year EFS rate was 45.2%
